{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T09:16:49.327376+00:00","published_at":"2026-10-17T04:46:55.096783+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:16rjw2914r0s9","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:esther-rajavelu","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Esther Rajavelu seat on Spero Therapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ilccandfe15j","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:kathleen-tregoning","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Kathleen Tregoning seat on Spero Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18x2itovnyud","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:kathleen-tregoning","alpha:committee:spero-therapeutics-inc:compensation"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_record:19"],"evidence_ids":["alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71"],"summary":"Kathleen Tregoning member of Compensation, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1x38837np7vx","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:scott-jackson","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Sharon L. Jackson seat on Spero Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7ryg11djdw8x","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:committee:spero-therapeutics-inc:audit-nominating-and-governance","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Audit; Nominating and Governance committee of Spero Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mi7tf11q5unh7","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:scott-jackson","alpha:committee:spero-therapeutics-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Sharon L. Jackson member of Audit; Nominating and Governance, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ywlri11vyf2v7","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Cynthia Smith seat on Spero Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:gaan8p78a6b","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:committee:spero-therapeutics-inc:compensation-chair","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Compensation · Chair committee of Spero Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:co3axq17b5ti2","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:committee:spero-therapeutics-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Cynthia Smith member of Compensation · Chair, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rtews21br210u","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:john-c-pottage-jr-m-d","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"John C. Pottage, Jr., M.D. seat on Spero Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:5vx75e1kvrfws","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:frank-e-thomas","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Frank E. Thomas seat on Spero Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1r6bprm1t0y0k4","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:committee:spero-therapeutics-inc:audit-chair","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Audit · Chair committee of Spero Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18rglmkelq94s","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:frank-e-thomas","alpha:committee:spero-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Frank E. Thomas member of Audit · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:u5lm8s1wsqmnu","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:patrick-vink-m-d","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Patrick Vink, M.D. seat on Spero Therapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8usm8wh0ffjs","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:milind-deshpande-ph-d","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Milind Deshpande, Ph.D. seat on Spero Therapeutics, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1y5tug430tjfy","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:ankit-mahadevia-m-d","alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3"],"caused_claim_ids":["alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c"],"summary":"Ankit Mahadevia, M.D. seat on Spero Therapeutics, Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:7","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ankit-mahadevia-m-d","object_label":"Ankit Mahadevia, M.D.","object_source_name_forms":[],"value":"Ankit Mahadevia, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ankit-mahadevia-m-d","name":"Ankit Mahadevia, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:8","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:cynthia-smith","object_label":"Cynthia Smith","object_source_name_forms":[],"value":"Cynthia Smith: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:9","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:esther-rajavelu","object_label":"Esther Rajavelu","object_source_name_forms":[],"value":"Esther Rajavelu: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:esther-rajavelu","name":"Esther Rajavelu"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:10","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:frank-e-thomas","object_label":"Frank E. Thomas","object_source_name_forms":[],"value":"Frank E. Thomas: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:frank-e-thomas","name":"Frank E. Thomas"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:11","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-c-pottage-jr-m-d","object_label":"John C. Pottage, Jr., M.D.","object_source_name_forms":[],"value":"John C. Pottage, Jr., M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-c-pottage-jr-m-d","name":"John C. Pottage, Jr., M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:12","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kathleen-tregoning","object_label":"Kathleen Tregoning","object_source_name_forms":[],"value":"Kathleen Tregoning: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kathleen-tregoning","name":"Kathleen Tregoning"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:13","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:milind-deshpande-ph-d","object_label":"Milind Deshpande, Ph.D.","object_source_name_forms":[],"value":"Milind Deshpande, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:milind-deshpande-ph-d","name":"Milind Deshpande, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:14","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:patrick-vink-m-d","object_label":"Patrick Vink, M.D.","object_source_name_forms":[],"value":"Patrick Vink, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:patrick-vink-m-d","name":"Patrick Vink, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:leadership_role:15","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:scott-jackson","object_label":"Sharon L. Jackson","object_source_name_forms":[],"value":"Sharon L. Jackson: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:scott-jackson","name":"Sharon L. Jackson"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:73c14dd4-c511-4915-b606-f728a4c281c3:committee_record:19","subject_id":"alpha:company:73c14dd4-c511-4915-b606-f728a4c281c3","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Cynthia Smith; Members Cynthia Smith (Chair); Kathleen Tregoning","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Cynthia Smith","members":[{"display_name":"Cynthia Smith","person_slug":"cynthia-smith","is_chair":true},{"display_name":"Kathleen Tregoning","person_slug":"kathleen-tregoning","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:faf3b03068a37efd6984d9a88af8c10ed035d245c231450f37208b17c3d8724c","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Spero Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:ce4ab61dbd7871fc39f3fe601ad1ae0a4a98b664435ec6e6a47498defe6f2e71","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312525100544/d797305ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.83,"cross_source_agreement":0.75,"temporal_completeness":0.643},"diagnostics":{"published_claims":23,"factual_claims":23,"claims_with_linked_evidence":23,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:55.096783+00:00","observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":"2026-10-17T04:46:55.096783+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/spero-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/spero-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}